R Luzzi

862 total citations
66 papers, 673 citations indexed

About

R Luzzi is a scholar working on Surgery, Complementary and alternative medicine and Internal Medicine. According to data from OpenAlex, R Luzzi has authored 66 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 11 papers in Complementary and alternative medicine and 8 papers in Internal Medicine. Recurrent topics in R Luzzi's work include Venous Thromboembolism Diagnosis and Management (8 papers), Diagnosis and Treatment of Venous Diseases (7 papers) and Medicinal Plants and Neuroprotection (6 papers). R Luzzi is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Diagnosis and Treatment of Venous Diseases (7 papers) and Medicinal Plants and Neuroprotection (6 papers). R Luzzi collaborates with scholars based in Italy, United States and Germany. R Luzzi's co-authors include Mark Dugall, Beatrice Feragalli, Umberto Cornelli, Gianni Belcaro, E. Ippolito, M R Cesarone, A Ledda, Masako Hosoi, Morio Hosoi and Gianni Belcaro and has published in prestigious journals such as Blood, Phytotherapy Research and Phytomedicine.

In The Last Decade

R Luzzi

64 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Luzzi Italy 15 150 127 108 106 99 66 673
Maria Giovanna Grossi Italy 10 151 1.0× 68 0.5× 55 0.5× 136 1.3× 195 2.0× 18 510
Ramazan Uygur Türkiye 13 104 0.7× 65 0.5× 28 0.3× 40 0.4× 67 0.7× 23 653
Morio Hosoi Italy 10 89 0.6× 80 0.6× 46 0.4× 52 0.5× 89 0.9× 61 429
Cláudia Rucco Penteado Detregiachi Brazil 15 267 1.8× 62 0.5× 42 0.4× 53 0.5× 81 0.8× 53 984
Nafiseh Shokri Mashhadi Iran 16 148 1.0× 34 0.3× 59 0.5× 67 0.6× 30 0.3× 60 801
Maryam Akbari‐Fakhrabadi Iran 10 106 0.7× 58 0.5× 34 0.3× 91 0.9× 32 0.3× 21 528
Young‐Sik Kim South Korea 14 158 1.1× 63 0.5× 45 0.4× 59 0.6× 15 0.2× 54 494
Majid Shokoohi Iran 22 176 1.2× 179 1.4× 56 0.5× 88 0.8× 12 0.1× 45 1.2k
Farihah Hj Suhaimi Malaysia 13 256 1.7× 106 0.8× 100 0.9× 61 0.6× 19 0.2× 27 847
Farnaz Farsi Iran 15 292 1.9× 84 0.7× 68 0.6× 36 0.3× 58 0.6× 44 873

Countries citing papers authored by R Luzzi

Since Specialization
Citations

This map shows the geographic impact of R Luzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Luzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Luzzi more than expected).

Fields of papers citing papers by R Luzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Luzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Luzzi. The network helps show where R Luzzi may publish in the future.

Co-authorship network of co-authors of R Luzzi

This figure shows the co-authorship network connecting the top 25 collaborators of R Luzzi. A scholar is included among the top collaborators of R Luzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Luzzi. R Luzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwiatkowski, Janet L., Sujit Sheth, Antonis Kattamis, et al.. (2024). Efficacy and Safety of Combination Therapy with Oral Iron Chelators Deferiprone and Deferasirox in Patients with β-Thalassemia Major: A Systematic Literature Review. Blood. 144(Supplement 1). 5268–5268.
2.
Belcaro, Gianni, Peter Rohdewald, M R Cesarone, et al.. (2022). Restless legs syndrome: prevention with Pycnogenol® and improvement of the venoarteriolar response. Panminerva Medica. 64(2). 253–258. 1 indexed citations
3.
Cotellese, Roberto, M R Cesarone, Gianni Belcaro, et al.. (2021). Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections. Panminerva Medica. 63(3). 343–348.
5.
Ledda, Andrea, Gianni Belcaro, Beatrice Feragalli, et al.. (2020). Temporary kidney dysfunction: supplementation with Meriva® in initial, transient kidney micro-macro albuminuria. Panminerva Medica. 61(4). 444–448. 8 indexed citations
6.
Belcaro, Gianni, M R Cesarone, Mark Dugall, et al.. (2019). Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth. PubMed. 67(6). 450–455. 2 indexed citations
7.
Hu, Shu, Morio Hosoi, Gianni Belcaro, et al.. (2019). Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®. PubMed. 67(5). 392–398. 1 indexed citations
8.
Hosoi, Morio, Gianni Belcaro, Aristide Saggino, et al.. (2018). Pycnogenol® supplementation in minimal cognitive dysfunction. Journal of Neurosurgical Sciences. 62(3). 279–284. 6 indexed citations
9.
Belcaro, G, Morio Hosoi, Beatrice Feragalli, R Luzzi, & Mark Dugall. (2018). Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress. Minerva Medica. 109(3). 211–217. 5 indexed citations
10.
Luzzi, R, Gianni Belcaro, Hu Shu, et al.. (2018). Efficacy of Pycnogenol® supplementation in remission phases of Sjögren syndrome. PubMed. 66(5). 543–546. 5 indexed citations
11.
Ledda, Andrea, Gianni Belcaro, Beatrice Feragalli, et al.. (2018). Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria. Panminerva Medica. 60(2). 60–64. 3 indexed citations
12.
Feragalli, Beatrice, Mark Dugall, R Luzzi, et al.. (2018). Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study. PubMed. 44(1). 97–101. 6 indexed citations
13.
Belcaro, G, Mark Dugall, R Luzzi, et al.. (2018). Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry. Minerva Medica. 109(2). 88–94. 9 indexed citations
14.
Luzzi, R, G Belcaro, Morio Hosoi, et al.. (2017). Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®. Minerva Obstetrics and Gynecology. 69(1). 29–34. 12 indexed citations
15.
Belcaro, Gianni, Mark Dugall, E. Ippolito, et al.. (2016). Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events. Minerva Cardiology and Angiology. 65(1). 17 indexed citations
16.
Dugall, Mark, R Luzzi, Massimiliano Marco Corsi Romanelli, et al.. (2016). Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings. International Journal of Angiology. 26(3). 170–178. 15 indexed citations
17.
Belcaro, G, Mark Dugall, Shen Hu, et al.. (2015). Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.. PubMed. 57(3). 121–5. 5 indexed citations
18.
Belcaro, Gianni, Mark Dugall, Masako Hosoi, et al.. (2014). Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.. PubMed. 33(1). 20–6. 15 indexed citations
19.
Belcaro, Gianni, Umberto Cornelli, R Luzzi, et al.. (2013). Pycnogenol® Supplementation Improves Health Risk Factors in Subjects with Metabolic Syndrome. Phytotherapy Research. 27(10). 1572–1578. 27 indexed citations
20.
Luzzi, R, Luiz Gonzaga Verdi, Edésio Luiz Simionatto, et al.. (1997). Isolation of biflavonoids with analgesic activity from Rheedia gardneriana leaves. Phytomedicine. 4(2). 141–144. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026